The 2018 ASCO Annual Meeting is just around the corner and we’re excited to bring our Sample to Insight solutions to Chicago on June1st-5th. We hope to see you there!
Delivering cutting-edge therapies globally and ensuring you make the best treatment decisions for your patients can be challenging in the continually evolving clinical oncology landscape. At QIAGEN we pride ourselves in keeping pace with clinical oncology discoveries, to offer a full range of tools that enable you to lead the way in developing targeted therapies, and to help guide treatment decisions.
Whether you are seeking a diagnostic for point-of-care or central laboratory testing, or a trusted partner to develop companion diagnostics for your new cancer therapy, we have products and expertise to meet your needs. From mono- to multiplex and syndromic testing*, from PCR to cutting edge NGS insights with guideline-focused reporting, we offer a full range of precision diagnostic solutions for your precision medicine.
Explore our solutions and speak with our experts in booth #5113. Interested in receiving a demo of one of our Sample to Insight offerings? Why not sign up in advance to book a demo with one of our team.
* Syndromic testing coming soon to the US